Course of cluster attacks during primary observational period. BOL-148... | Download Scientific Diagram
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series - Matthias Karst, John H Halpern, Michael Bernateck, Torsten Passie, 2010
Research & Development - Ceruvia Lifesciences
The Use of LSD, Psilocybin, and Bromo-LSD for the Treatment of Cluster Headaches - Torsten Passie - YouTube
Graham Pechenik on Twitter: "An overview of the 2-Bromo-LSD (BOL-148) synthesis patent appears in the November deck of Transcend Biodynamics, recently acquired in a C$10 million all-stock deal by BetterLife Pharma. h/t @
Ceruvia Lifesciences on LSD and BOL-148
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders - ScienceDirect
2-Bromo-LSD - Wikipedia
BetterLife Pharma Is Developing Second Generation Psychedelics: Drugs That Leave Out The Trip